KDELR1
gene geneOn this page
Also known as ERD2.1ERD2HDEL
Summary
KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1, HGNC:6304) is a protein-coding gene on chromosome 19q13.33, encoding ER lumen protein-retaining receptor 1 (P24390). Receptor for the C-terminal sequence motif K-D-E-L that is present on endoplasmic reticulum resident proteins and that mediates their recycling from the Golgi back to the endoplasmic reticulum.
Retention of resident soluble proteins in the lumen of the endoplasmic reticulum (ER) is achieved in both yeast and animal cells by their continual retrieval from the cis-Golgi, or a pre-Golgi compartment. Sorting of these proteins is dependent on a C-terminal tetrapeptide signal, usually lys-asp-glu-leu (KDEL) in animal cells, and his-asp-glu-leu (HDEL) in S. cerevisiae. This process is mediated by a receptor that recognizes, and binds the tetrapeptide-containing protein, and returns it to the ER. In yeast, the sorting receptor encoded by a single gene, ERD2, which is a seven-transmembrane protein. Unlike yeast, several human homologs of the ERD2 gene, constituting the KDEL receptor gene family, have been described. The protein encoded by this gene was the first member of the family to be identified, and it encodes a protein structurally and functionally similar to the yeast ERD2 gene product.
Source: NCBI Gene 10945 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 26 total
- Druggable target: yes
- MANE Select transcript:
NM_006801
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6304 |
| Approved symbol | KDELR1 |
| Name | KDEL endoplasmic reticulum protein retention receptor 1 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ERD2.1, ERD2, HDEL |
| Ensembl gene | ENSG00000105438 |
| Ensembl biotype | protein_coding |
| OMIM | 131235 |
| Entrez | 10945 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 retained_intron
ENST00000330720, ENST00000594643, ENST00000597017, ENST00000599084, ENST00000600980, ENST00000932964, ENST00000932965, ENST00000943172
RefSeq mRNA: 1 — MANE Select: NM_006801
NM_006801
CCDS: CCDS12718
Canonical transcript exons
ENST00000330720 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000717479 | 48384230 | 48384482 |
| ENSE00001131365 | 48389553 | 48389711 |
| ENSE00001131388 | 48391268 | 48391551 |
| ENSE00001250873 | 48382575 | 48383327 |
| ENSE00003636044 | 48390424 | 48390524 |
Expression profiles
Bgee: expression breadth ubiquitous, 273 present calls, max score 98.88.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 255.6435 / max 1673.8309, expressed in 1827 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181843 | 253.1318 | 1827 |
| 181842 | 2.5118 | 1299 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 98.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 98.85 | gold quality |
| left ovary | UBERON:0002119 | 98.47 | gold quality |
| right ovary | UBERON:0002118 | 98.33 | gold quality |
| endometrium epithelium | UBERON:0004811 | 98.33 | gold quality |
| endocervix | UBERON:0000458 | 98.26 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 98.16 | gold quality |
| pylorus | UBERON:0001166 | 98.08 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.03 | gold quality |
| minor salivary gland | UBERON:0001830 | 98.03 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.03 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 98.02 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.01 | gold quality |
| superficial temporal artery | UBERON:0001614 | 98.01 | gold quality |
| right coronary artery | UBERON:0001625 | 98.00 | gold quality |
| rectum | UBERON:0001052 | 97.99 | gold quality |
| body of pancreas | UBERON:0001150 | 97.98 | gold quality |
| cardia of stomach | UBERON:0001162 | 97.98 | gold quality |
| body of stomach | UBERON:0001161 | 97.95 | gold quality |
| adenohypophysis | UBERON:0002196 | 97.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.94 | gold quality |
| gall bladder | UBERON:0002110 | 97.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.94 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.93 | gold quality |
| transverse colon | UBERON:0001157 | 97.89 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.89 | gold quality |
| renal medulla | UBERON:0000362 | 97.88 | gold quality |
| left uterine tube | UBERON:0001303 | 97.87 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 97.87 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.87 | gold quality |
Single-cell (SCXA)
Detected in 9 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-88 | yes | 81.49 |
| E-HCAD-4 | yes | 46.46 |
| E-CURD-122 | yes | 37.67 |
| E-HCAD-10 | yes | 27.06 |
| E-ANND-3 | yes | 22.01 |
| E-CURD-46 | yes | 19.72 |
| E-MTAB-10042 | yes | 10.92 |
| E-MTAB-10553 | yes | 9.74 |
| E-HCAD-13 | no | 3.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
72 targeting KDELR1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
Literature-anchored findings (GeneRIF, showing 15)
- the KDEL receptor participates in the ER stress response not only by its retrieval ability but also by modulating MAP kinase signaling (PMID:12821650)
- Src relocated the KDEL receptor (KDEL-R) from the Golgi apparatus to the endoplasmic reticulum (PMID:12975382)
- our data provide evidence that KDELR, as a novel inducer of autophagy, participates in the degradation of misfolded neurodegenerative disease-related proteins. (PMID:21684323)
- Cystinosin, MPDU1, SWEETs and KDELR belong to a well-defined protein family with putative function of cargo receptors. (PMID:22363504)
- These findings reveal an unexpected GPCR-like mode of action of the KDEL-R and shed light on a core molecular control mechanism of intra-Golgi traffic. (PMID:22580821)
- It discuss the particular role of KDEL receptor signaling in the regulation of important pathways involved in the maintenance of the homeostasis of the transport apparatus, and in particular, of the Golgi complex. (PMID:23873287)
- KDEL receptor activates CREB1 and other transcription factors that upregulate transport-related genes (PMID:25117681)
- A Golgi-based KDELR-dependent signalling pathway controls invadopodia-dependent extracellular matrix degradation. (PMID:25682866)
- We propose a model whereby in analogy to previous findings (e.g., the RAS-RAF signalling pathway), PHB can act as a signalling scaffold protein to assist in KDELR-dependent Src activation (PMID:26064897)
- KDELR protein mediated the intracellular trafficking of Japanese encephalitis virus particles. (PMID:26861384)
- Data show that Golgi-based, KDEL receptor-dependent signalling promotes lysosome repositioning to the perinuclear area, involving a complex process intertwined to autophagy, lipid-droplet turnover and Golgi-mediated secretion. (PMID:30760704)
- The cell surface trafficking of PDIA1, PDIA3, and PDIA6 is dependent on KDELR1, which travels in a dynamic manner to the cell surface. This transport is assumed to result in PDI cell surface association, which differs from PDI inducible secretion into the extracellular space. (PMID:30958660)
- Transcriptomics of a KDELR1 knockout cell line reveals modulated cell adhesion properties. (PMID:31337861)
- KDEL receptor is a cell surface receptor that cycles between the plasma membrane and the Golgi via clathrin-mediated transport carriers. (PMID:32562023)
- Cell-type-specific differences in KDEL receptor clustering in mammalian cells. (PMID:32645101)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Kdelr1 | ENSMUSG00000002778 |
| rattus_norvegicus | Kdelr1 | ENSRNOG00000021082 |
| drosophila_melanogaster | KdelR | FBGN0267330 |
| caenorhabditis_elegans | WBGENE00001331 | |
| caenorhabditis_elegans | WBGENE00016195 |
Paralogs (2): KDELR3 (ENSG00000100196), KDELR2 (ENSG00000136240)
Protein
Protein identifiers
ER lumen protein-retaining receptor 1 — P24390 (reviewed: P24390)
Alternative names: KDEL endoplasmic reticulum protein retention receptor 1, Putative MAPK-activating protein PM23
All UniProt accessions (2): P24390, M0R1Y2
UniProt curated annotations — full annotation on UniProt →
Function. Receptor for the C-terminal sequence motif K-D-E-L that is present on endoplasmic reticulum resident proteins and that mediates their recycling from the Golgi back to the endoplasmic reticulum.
Subunit / interactions. Upon ligand binding the receptor oligomerizes and interacts with components of the transport machinery such as ARFGAP1 and ARF1.
Subcellular location. Golgi apparatus membrane. Cytoplasmic vesicle. COPI-coated vesicle membrane. Endoplasmic reticulum membrane. Endoplasmic reticulum-Golgi intermediate compartment membrane.
Post-translational modifications. Phosphorylation by PKA at Ser-209 is required for endoplasmic reticulum retention function.
Domain organisation. Binds the C-terminal sequence motif K-D-E-L in a hydrophilic cavity between the transmembrane domains. This triggers a conformation change that exposes a Lys-rich patch on the cytosolic surface of the protein. This patch mediates recycling from the Golgi to the endoplasmic reticulum, probably via COPI vesicles.
Similarity. Belongs to the ERD2 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P24390-1 | 1 | yes |
| P24390-2 | 2 |
RefSeq proteins (1): NP_006792* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000133 | ER_ret_rcpt | Family |
Pfam: PF00810
UniProt features (34 total): mutagenesis site 10, topological domain 8, transmembrane region 7, region of interest 3, site 3, chain 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P24390-F1 | 92.66 | 0.84 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 5 (interaction with the k-d-e-l motif on target proteins); 117 (interaction with the k-d-e-l motif on target proteins); 193 (important for recycling of cargo proteins with the sequence motif k-d-e-l from the golgi to the endoplasmic reticulum)
Post-translational modifications (1): 209
Mutagenesis-validated functional residues (10):
| Position | Phenotype |
|---|---|
| 12 | loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r |
| 32 | decreased binding to the sequence motif k-d-e-l. |
| 47 | loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r |
| 91–92 | decreased binding to the sequence motif k-d-e-l. |
| 127 | loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r |
| 158 | loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r |
| 193 | loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r |
| 204–207 | loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r |
| 209 | inhibits coatomer/arf-gap recruitment, receptor redistribution, and intracellular retention of kdel ligands. |
| 209 | redistribution to the er is not affected upon pka inactivation. |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6807878 | COPI-mediated anterograde transport |
| R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic |
| R-HSA-9918476 | Assembly and Release of Dengue Virus Virions |
MSigDB gene sets: 213 (showing top):
MORF_MTA1, RNGTGGGC_UNKNOWN, SWEET_KRAS_ONCOGENIC_SIGNATURE, TTTGTAG_MIR520D, SP3_Q3, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM, GOBP_MAINTENANCE_OF_LOCATION, MORF_RAB6A, GOCC_COATED_VESICLE, GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE, GOCC_GOLGI_ASSOCIATED_VESICLE, GOBP_LEUKOCYTE_APOPTOTIC_PROCESS
GO Biological Process (6): protein retention in ER lumen (GO:0006621), retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), protein transport (GO:0015031), T cell differentiation (GO:0030217), T cell apoptotic process (GO:0070231), vesicle-mediated transport (GO:0016192)
GO Molecular Function (3): KDEL sequence binding (GO:0005046), ER lumen protein retrieval receptor activity (GO:0046923), protein binding (GO:0005515)
GO Cellular Component (11): Golgi membrane (GO:0000139), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), cis-Golgi network (GO:0005801), transport vesicle (GO:0030133), COPI-coated vesicle membrane (GO:0030663), endoplasmic reticulum-Golgi intermediate compartment membrane (GO:0033116), Golgi apparatus (GO:0005794), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| ER to Golgi Anterograde Transport | 1 |
| Golgi-to-ER retrograde transport | 1 |
| Dengue Virus Infection | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| intracellular membrane-bounded organelle | 4 |
| endomembrane system | 3 |
| transport | 2 |
| Golgi apparatus | 2 |
| bounding membrane of organelle | 2 |
| maintenance of protein localization in endoplasmic reticulum | 1 |
| Golgi vesicle transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| lymphocyte differentiation | 1 |
| T cell activation | 1 |
| lymphocyte apoptotic process | 1 |
| cellular process | 1 |
| ER lumen protein retrieval receptor activity | 1 |
| signal sequence receptor activity | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cytoplasmic vesicle | 1 |
| COPI-coated vesicle | 1 |
| Golgi-associated vesicle membrane | 1 |
| coated vesicle membrane | 1 |
| endoplasmic reticulum-Golgi intermediate compartment | 1 |
| cellular anatomical structure | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
1118 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KDELR1 | SDF2L1 | Q9HCN8 | 866 |
| KDELR1 | SDF2 | Q99470 | 848 |
| KDELR1 | RCN1 | Q15293 | 840 |
| KDELR1 | COPB1 | P53618 | 832 |
| KDELR1 | RCN2 | Q14257 | 819 |
| KDELR1 | GOLPH3 | Q9H4A6 | 799 |
| KDELR1 | RER1 | O15258 | 692 |
| KDELR1 | SURF4 | O15260 | 683 |
| KDELR1 | SEC63 | Q9UGP8 | 635 |
| KDELR1 | POMT2 | Q9UKY4 | 607 |
| KDELR1 | POMT1 | Q9Y6A1 | 582 |
| KDELR1 | PREB | Q9HCU5 | 576 |
| KDELR1 | SEC13 | P55735 | 565 |
| KDELR1 | SEC61A1 | P38378 | 551 |
| KDELR1 | CALR | P27797 | 523 |
IntAct
84 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| CFTR | HAX1 | psi-mi:“MI:0914”(association) | 0.610 |
| KRT34 | KDELR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KDELR1 | DLG2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KDELR1 | DLG3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KDELR1 | TRAFD1 | psi-mi:“MI:0914”(association) | 0.530 |
| APLNR | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM63A | AP3D1 | psi-mi:“MI:0914”(association) | 0.530 |
| CLCC1 | PLSCR1 | psi-mi:“MI:0914”(association) | 0.530 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| COPB1 | KDELR1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KDELR1 | SEC23A | psi-mi:“MI:0915”(physical association) | 0.400 |
| KDELR1 | KDELR1 | psi-mi:“MI:2364”(proximity) | 0.380 |
| KDELR1 | KDELR1 | psi-mi:“MI:0403”(colocalization) | 0.380 |
| KDELR1 | CCR9 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KDELR1 | F2RL1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KDELR1 | GPR35 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRK2 | psi-mi:“MI:0914”(association) | 0.350 | |
| KDELR1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| RAC1 | psi-mi:“MI:0914”(association) | 0.350 | |
| PRKAR1A | ADAM10 | psi-mi:“MI:0914”(association) | 0.350 |
| PEBP1 | ANXA2P2 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (128): KDELR1 (Affinity Capture-MS), UBE3A (Affinity Capture-MS), UBL7 (Affinity Capture-MS), FAM63A (Affinity Capture-MS), VPS36 (Affinity Capture-MS), TAX1BP1 (Affinity Capture-MS), TRAFD1 (Affinity Capture-MS), UCHL5 (Affinity Capture-MS), PSMD11 (Affinity Capture-MS), UBQLN4 (Affinity Capture-MS), NPLOC4 (Affinity Capture-MS), PSMD12 (Affinity Capture-MS), PSMD6 (Affinity Capture-MS), UBQLN1 (Affinity Capture-MS), RNF115 (Affinity Capture-MS)
ESM2 similar proteins: A0A097ZPD8, A0A0E3D8M2, A0A0E3D8Q2, A0A0F7TZE0, A0A0U5GIU9, A0A140JWT2, A0A1B7YCX1, A0A1E1FFM9, A0A1Y0BRF5, A0A2I1BT01, A0A2I6PJ07, A0A2P1DP74, A0A3G9H8P0, A0A3T0ZHJ5, A0A455RAK9, A0A8D5M7T9, A9JPE3, B6HV37, E3UBL6, E9F5E8, J7FIJ6, K2RU64, M1VJS5, P0DY23, P24390, P33946, P35402, P48583, P9WEQ3, P9WEX1, P9WEX7, P9WEY0, Q0VCC1, Q15FB1, Q4WBI3, Q4WLD2, Q569A6, Q5M880, Q5U305, Q5XHA2
Diamond homologs: O42580, O43731, O44017, O76767, O94270, P18413, P18414, P24390, P33946, P33947, P33948, P35402, P48583, Q09473, Q2KJ37, Q569A6, Q5U305, Q5XHA2, Q5ZKX9, Q611C8, Q66JF2, Q68ES4, Q6P257, Q6PAB8, Q6PEH1, Q6PFS5, Q76NM1, Q7ZXS5, Q86JE5, Q8R1L4, Q8VWI1, Q99JH8, Q9CQM2, Q9ZTN2
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PRKACA | up-regulates | KDELR1 | phosphorylation |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 100 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| positive regulation of cytosolic calcium ion concentration | 8 | 11.0× | 3e-04 |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 7 | 9.3× | 3e-03 |
| G protein-coupled receptor signaling pathway | 14 | 6.0× | 7e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
711 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:48383323:TAGGA:T | acceptor_gain | 1.0000 |
| 19:48383325:GGA:G | acceptor_gain | 1.0000 |
| 19:48383326:GA:G | acceptor_gain | 1.0000 |
| 19:48383326:GAC:G | acceptor_loss | 1.0000 |
| 19:48383328:C:CC | acceptor_gain | 1.0000 |
| 19:48383329:T:C | acceptor_loss | 1.0000 |
| 19:48383330:G:C | acceptor_gain | 1.0000 |
| 19:48384225:GCTAC:G | donor_loss | 1.0000 |
| 19:48384226:CTACC:C | donor_loss | 1.0000 |
| 19:48384227:TAC:T | donor_loss | 1.0000 |
| 19:48384228:A:AT | donor_loss | 1.0000 |
| 19:48384229:CCTTT:C | donor_loss | 1.0000 |
| 19:48389548:CCTA:C | donor_loss | 1.0000 |
| 19:48389549:CTAC:C | donor_loss | 1.0000 |
| 19:48389550:TA:T | donor_loss | 1.0000 |
| 19:48389551:A:AT | donor_loss | 1.0000 |
| 19:48389708:CCAC:C | acceptor_gain | 1.0000 |
| 19:48389709:CACC:C | acceptor_gain | 1.0000 |
| 19:48389710:ACC:A | acceptor_loss | 1.0000 |
| 19:48389711:CCT:C | acceptor_loss | 1.0000 |
| 19:48389712:CTGA:C | acceptor_loss | 1.0000 |
| 19:48389713:T:G | acceptor_loss | 1.0000 |
| 19:48390421:TACCT:T | donor_loss | 1.0000 |
| 19:48390422:ACC:A | donor_loss | 1.0000 |
| 19:48390423:CC:C | donor_loss | 1.0000 |
| 19:48390525:C:A | acceptor_loss | 1.0000 |
| 19:48390525:C:CC | acceptor_gain | 1.0000 |
| 19:48390533:C:CT | acceptor_gain | 1.0000 |
| 19:48390534:A:T | acceptor_gain | 1.0000 |
| 19:48391286:T:TA | donor_gain | 1.0000 |
AlphaMissense
1376 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:48384284:C:G | G184R | 1.000 |
| 19:48384368:C:G | G156R | 1.000 |
| 19:48384436:G:C | P133R | 1.000 |
| 19:48384436:G:T | P133Q | 1.000 |
| 19:48391336:C:T | G8E | 1.000 |
| 19:48384252:G:C | F194L | 0.999 |
| 19:48384252:G:T | F194L | 0.999 |
| 19:48384254:A:G | F194L | 0.999 |
| 19:48384283:C:T | G184D | 0.999 |
| 19:48384286:G:T | A183E | 0.999 |
| 19:48384328:C:G | R169P | 0.999 |
| 19:48384329:G:T | R169S | 0.999 |
| 19:48384338:A:G | W166R | 0.999 |
| 19:48384338:A:T | W166R | 0.999 |
| 19:48384339:G:C | N165K | 0.999 |
| 19:48384339:G:T | N165K | 0.999 |
| 19:48384358:C:G | R159P | 0.999 |
| 19:48384359:G:T | R159S | 0.999 |
| 19:48384367:C:T | G156D | 0.999 |
| 19:48384370:A:G | L155P | 0.999 |
| 19:48384379:A:G | L152S | 0.999 |
| 19:48384430:A:G | L135P | 0.999 |
| 19:48384437:G:A | P133S | 0.999 |
| 19:48384437:G:T | P133T | 0.999 |
| 19:48384442:A:T | I131N | 0.999 |
| 19:48384445:G:T | A130D | 0.999 |
| 19:48384446:C:G | A130P | 0.999 |
| 19:48384453:C:A | E127D | 0.999 |
| 19:48384453:C:G | E127D | 0.999 |
| 19:48384454:T:A | E127V | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000125913 (19:48392020 G>A), RS1000319960 (19:48397051 C>T), RS1000409250 (19:48392748 C>A,G,T), RS1000743486 (19:48390748 A>C), RS1000817332 (19:48386117 T>C), RS1000984746 (19:48397615 T>C), RS1001059588 (19:48396158 T>A,C), RS1001122510 (19:48383445 T>A,C,G), RS1001215324 (19:48384627 C>T), RS1001594456 (19:48395912 TG>T), RS1001627022 (19:48396129 A>G), RS1001698775 (19:48391868 G>C), RS1001778538 (19:48396802 G>A), RS1001800324 (19:48391755 CTG>C), RS1001964026 (19:48395288 C>G,T)
Disease associations
OMIM: gene MIM:131235 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066272 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 4 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 9.60 | Kd | 0.253 | nM | CHEMBL5653589 |
| 9.60 | ED50 | 0.253 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 4 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148618: Binding affinity to human KDELR1 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0003 | uM |
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | increases expression | 1 |
| ginger extract | affects cotreatment, affects expression, increases abundance | 1 |
| alpha-pinene | increases abundance, affects cotreatment, increases oxidation | 1 |
| bisphenol A | affects cotreatment, affects expression, increases abundance | 1 |
| deoxynivalenol | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| U 0126 | affects expression, affects reaction | 1 |
| bisphenol B | increases expression | 1 |
| abrine | decreases expression | 1 |
| Bortezomib | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Decitabine | affects methylation | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acrolein | increases abundance, affects cotreatment, increases oxidation | 1 |
| Air Pollutants | increases oxidation, affects cotreatment, increases abundance | 1 |
| Arsenic | increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Diazinon | increases methylation | 1 |
| Ivermectin | decreases expression | 1 |
| Methotrexate | affects response to substance | 1 |
| Oils, Volatile | affects cotreatment, affects expression, increases abundance | 1 |
| Ozone | affects cotreatment, increases oxidation, increases abundance | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651660 | Binding | Binding affinity to human KDELR1 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
3 cell lines: 2 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2ZK | Abcam HEK293T KDELR1 KO | Transformed cell line | Female |
| CVCL_SU14 | HAP1 KDELR1 (-) 1 | Cancer cell line | Male |
| CVCL_XP95 | HAP1 KDELR1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.